MOLN vs VRTX: Which Stock is Better?

Side-by-side comparison of Molecular Partners Ag and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

MOLN

Molecular Partners Ag

$5.00

VRTX

Vertex Pharmaceuticals Inc

$456.69

Key Metrics Comparison

MetricMOLNVRTXWinner
Market Cap$184.38M$116.00BVRTX
P/E RatioN/A30.12VRTX
EPS (TTM)$N/A$15.16VRTX
Revenue Growth-1.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze MOLN

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MOLN or VRTX a better investment?

Comparing MOLN and VRTX: Molecular Partners Ag has a market cap of $184.38M while Vertex Pharmaceuticals Inc has $116.00B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MOLN and VRTX?

MOLN (Molecular Partners Ag) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MOLN or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MOLN or VRTX?

VRTX has higher revenue growth at 0.1% vs -1.0% for MOLN.

Which company is more profitable: MOLN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for MOLN.

Which is the larger company: MOLN or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $116.00B compared to $184.38M for MOLN.

Should I buy MOLN or VRTX in 2026?

Both MOLN and VRTX have investment merit. MOLN trades at $5.00 while VRTX trades at $456.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MOLN and VRTX stock?

Key differences: Market Cap ($184.38M vs $116.00B), P/E Ratio (N/A vs 30.1x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons